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Development of Cataractous Macrophthalmia in Mice
Expressing an Active MEK1 in the Lens
Xiaohua Gong,1 Xin Wang,1 Jiahuai Han,2 Ingrid Niesman,1 Qingling Huang,3
and Joseph Horwitz3
PURPOSE. To characterize the extracellular signal-regulated ki-
nase (ERK) pathway in the lens and to try to understand how
this pathway contributes to lens function and cataractogenesis.
METHODS. The members of the ERK pathway in the lens were
examined by Western blotting, immunohistochemical staining,
and kinase assay. A gain-of-function approach was used to
perturb the ERK pathway in the lenses of transgenic mice via
expression of a constitutively active mutant of the mitogen-
activated protein kinase kinase 1 (MEK1(E)), the direct up-
stream kinase of the ERK1 and ERK2 kinases, under the aA-
crystallin promoter.
RESULTS. The presence of an active ERK pathway was found in
lens epithelial cells and in differentiating fibers. Transgenic
mice that expressed MEK1(E) developed postnatal cataracts as
well as macrophthalmia. Distinct morphologic alterations,
such as lens enlargement, swelling fiber cells, enlarged extra-
cellular space, and vacuole formation, were observed in the
lenses of these transgenic mice. A significant increase in the
glucose transporter 1 (GLUT1) level, as well as in the glucose
level, was detected in the lens.
CONCLUSIONS. The MAP kinase pathway is involved in the reg-
ulation of glucose metabolism and balance in the mouse lens.
Moreover, the alteration of MAP kinase activity in the lens is
sufficient to cause cataract formation with enlarged extracel-
lular space and vacuoles in the differentiating fibers. This
transgenic mouse may provide a useful model for understand-
ing the mechanism(s) for some aspects of human cataracts.
(Invest Ophthalmol Vis Sci. 2001;42:539–548)
The lens is a highly organized, transparent, refractive, andavascular organ. The specific function of the lens is to form
an image by refracting and focusing light onto the retina. The
mammalian lens consists of a bundle of lens fibers covered by
a single layer of epithelial cells on its anterior hemisphere
surface.1 The continuing growth of the lens is dependent on
the generation of secondary fiber cells from the epithelial cells.
The newly differentiating secondary fibers lie on top of the
previous generation of fibers in a concentric manner in the
bow region of the lens. Eventually, these differentiating fibers
eliminate their intracellular organelles to become mature fi-
bers.2 The lens epithelial cells and the outer fibers comprising
the lens cortex possess the major metabolic machinery of the
whole lens. The lenticular body must be organized at the
molecular and structural levels, with control mechanisms main-
taining short-range order of macromolecules and lens transpar-
ency.3
Cataracts are the opacification of the lens that causes im-
paired vision, and they are still the major cause of blindness in
humans. Although cataracts appear mostly in elderly popula-
tions as an effect of aging or environmental and nutritional
stresses, lens opacities may develop rapidly as a consequence
of metabolic diseases, such as diabetes.4 Many studies have
attempted to understand diabetic cataracts through the use of
a variety of animal or cell models, generated by special dietary
administration of different sugars or other chemical reagents
with various methods.5–7 The limitation of these approaches is
that they cannot determine whether the initiation event for the
alteration of glucose metabolism in the lens is due solely to an
elevated intracellular glucose level or whether it is the result of
some other event occurring simultaneously, such as an activa-
tion of intracellular signaling pathways.8,9 In particular, it is
known that an elevated glucose level in the blood precedes the
appearance of diabetic cataracts in human patients.6
There is evidence that the mitogen-activated protein (MAP)
kinase plays an essential role in controlling cell proliferation,
differentiation, and many other cellular responses in a variety
of biological systems.10 The ERK pathway is normally referred
to as the classic MAP kinase pathway,10,11 and it has been
reported to be activated by UV radiation, oxidants, high glu-
cose levels, shock, and cytokines.12,13 There is evidence sug-
gesting that some of these environmental stresses are the risk
factors for causing human senile or diabetic cataracts.5–7 Thus,
we have hypothesized that MAP kinase pathways play a role in
normal lens development and in pathologic responses to envi-
ronmental stresses. Furthermore, the MAP kinases are likely to
be the downstream signaling members of the growth factors.
Perturbation of the FGF signaling pathway via overexpres-
sion of FGFs14–16 or dominant-negative receptors17,18 resulted
in microphthalmia with alterations in lens epithelial cells and
fiber cells in mice. However, the intracellular signaling path-
ways that mediate these growth factors in the lens are not well
understood.19 To explore the role of the ERK pathway in the
lens and to try to mimic a chronic activation of it under
environmental stresses during a lifetime, we have selected a
gain-of-function approach through an expression in transgenic
mice of a constitutively active mutant MEK1(E) kinase, driven
to the lens by the aA-crystallin promoter. The MEK1(E) kinase
is the direct upstream kinase of the ERK1 and ERK2 kinases.
The present report demonstrates that the expression of
MEK1(E) in transgenic mice is associated with severe impair-
ment of the glucose level and/or glucose transport in the lens.
This metabolic stress is associated with macrophthalmia and
lens opacities that are similar to some aspects of human cata-
racts.
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A R T I C L E S
METHODS
All scientific methods described in this article adhered to the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research.
Generation of Transgenic Mice
The constructs that express a constitutively active form of kinases
under the control of the aA-crystallin gene promoter20,21 were gener-
ated and injected into fertilized embryos of the inbred C57BL/6J strain
to produce the transgenic founder mice (F0).
Rat MEK1(E) cDNAs that encode constitutively active kinases were
provided by Jiahuai Han. MEK1(E) cDNA encodes a constitutively
active form of MEK1 by replacement of both serine residues (Ser-218
and Ser-222) with glutamic acid residues to mimic phosphorylation in
the activated form.22 The MEK1(E) cDNA (1.2 kb) was subcloned into
the CPV2 expression vector provided by Paul Overbeek at Baylor
College of Medicine.23 A 2.5-kb fragment containing an aA-promoter-
MEK1(E)-SV40pA region was used to generate the transgenic mice.
A PCR method was used to detect the transgene from mouse tail
DNA. The 59 primer is an oligo Ap (CCCAGAGGCTCCTGTCTGAC
1917–1936 bp of GenBank accession no. S79462). The 39 primer for
MEK1(E) is an oligo K1p (TGTGCTCCATGCAGATGCTG 436–417 of
GenBank accession no. D14591). A 550-bp PCR fragment was detected
from the tail DNA of CPV2-MEK1 transgenic mice by using this pair of
primers, as indicated in Figure 1A.
Western Blot Analysis
A standard Western blot procedure provided by the manufacturer was
used to carry out the analyses. The representative data shown in the
figures were taken from more than three independent experiments.
We prepared homogenates from the total lens, the lens cortex (includ-
ing epithelial cells), and the lens nucleus of mice. The lens was
arbitrarily separated into the lens cortex (including epithelial cells) and
the lens nucleus, as we have done in previous articles.24,25 These lens
samples were directly homogenized in 13 sample buffer (60 mM Tris,
pH 6.8, 2% SDS, 10 mM DTT, and 10% glycerol) according to the ratio
of 10 mg of lens wet weight per 400 ml of buffer. Equal amounts of
these homogenates were loaded onto SDS-PAGE for Western blot
analysis.
Antibodies against MEK1, MEK2, ERK1, ERK2, GLUT1, GLUT3, and
CIC-3 were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). The antibodies against the phosphorylated forms of ERK1/2,
p38, and JNK1/2 were purchased from New England Biolabs (Beverly,
MA). The antibodies against phospho-tyrosine were purchased from
Signal Transduction. Antibodies against a3 connexin (Cx46), a8 con-
nexin (Cx50), MP26, and MP20 were rabbit polyclonal antibodies.
Kinase Assay
Lens homogenized samples were prepared from the decapsulated
lenses and examined for their kinase activities. Nonradioactive kinase
FIGURE 1. Activation of the ERK pathway in the lens epithelium and differentiating fiber cells. (A) The homogenates of the total lens (1), lens
cortex (2), and lens nucleus (3) were examined for ERK1 and ERK2 kinases, the phosphorylated forms of ERK1 and ERK2 (pERK1 and pERK2),
MEK2, and a3 connexin (b) by Western blotting. The connexin a3 (Cx46) antigen was used as a control for the separation of the lens cortex and
lens nucleus. The intact a3 connexin was detected only in the lens cortical homogenate, whereas the cleaved forms of a3 connexin were found
in the lens nuclear homogenate. The samples were prepared from 6-week-old mice. (B) Laser-confocal microscopic images of immunohistochem-
ical stainings of the phosphorylated forms of ERKs (pERK) and MEK1 in the frozen lens sections from 6-week-old mice through the use of their
specific antibodies. Left: differential interference contrast (DIC) pictures of these sections; right: FITC-stained results of the anti-pERK antibody
(top) and the anti-MEK1 antibody (bottom). Large arrows, lens epithelium; small arrows, cellular nucleus of the differentiating fibers in the bow
region. Scale bar, 10 mm.
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activity assay kits for ERK1 and ERK2 kinases were purchased from
New England Biolabs, Inc. The experimental procedures were per-
formed according to the protocol provided by the manufacturer. Ac-
tive ERKs phosphorylated an Elk-1 fusion protein in the presence of
ATP and kinase buffer. Phosphorylation of Elk at Ser383 was measured
through Western blot analysis, using a phospho-Elk-1 (Ser383) anti-
body provided in the kit.
Histologic Analysis and Immunohistochemical
Staining
The hematoxylin and eosin–stained sections were prepared from these
mouse eyes by standard methods.24 Similarly, standard methods were
used for the antibody staining of the frozen lens sections.24 A laser-
confocal microscope (model 1024; BioRad, Hercules, CA) was used to
collect the staining results.
Transmission Electron Microscopic Analysis
Mouse lenses were fixed in 2.5% gluteraldehyde with 0.075 M of
cacodylate buffer, pH 7.2, overnight at 4°C. The fixative was changed
daily for a total fixation time of 5 days at 4°C. After extensive washes
in 0.1 M cacodylate buffer, lenses were post-fixed in 1% OsO4 for 1
hour at room temperature, stained with 0.5% tannic acid/0.05 M
cacodylate buffer for 1 hour, and neutralized with 1% Na2SO4 in 0.1 M
cacodylate buffer for 15 minutes. Lenses were then stained en bloc
with 1% uranyl acetate/10% ethanol for 15 minutes and further dehy-
drated in a standard ethanol series with two changes of 95% and 100%.
Ethanol was exchanged with HPMA and lenses were infiltrated over-
night in a 1:1 ratio of HPMA/LX112 (Ladd Scientific, Burlington, VT)
mixture while rotating. Lenses were embedded in LX112 after one
change of 100% LX112 for 4 hours and polymerized for 24 to 36 hours
at 60°C. Sample blocks were sectioned at 70 to 80 nm. Each grid was
contrasted with uranyl acetate and lead citrate before transmission
electron microscopic (TEM) inspection.
Measurement of Lens Glucose Concentration
Two lenses from one mouse were deproteinized by homogenization
with 150 ml of perchloric acid solution (6% HClO4), followed by
centrifugation at 13,000 rpm for 10 minutes at 4°C. The supernatants
were neutralized with 35 ml of 2 M K2CO3 followed by centrifugation
at 13,000 rpm for 10 minutes at 4°C. One hundred microliters of the
neutralized supernatant per sample was used for assaying the glucose
amount according to the procedure provided by the manufacture
(diagnostic glucose [HK] 10 kit; Sigma, St. Louis, MO). The lens glucose
concentration was calculated from the glucose amount (per lens) and
its volume. Because the mouse lens is almost like a sphere, we calcu-
lated the lens volume, 1/6 pD3, as if it were a sphere, using the
equatorial diameter (D).

FIGURE 2. Generation and characterization of the MEK1(E) transgenic
mice. (A) The generation of the transgenic mice. (a) The physical map
of the MEK1(E) construct used for generating the MEK1(E) transgenic
mice. MEK1(E) cDNA was inserted between the aA-crystallin promoter
(aAp) and the DNA fragment of an intron and polyadenylation se-
quence of the small t antigen from the SV40 virus (SV40pA). The
primers Ap and K1p (arrows) were used for mouse genotyping by
PCR. (b) The tail DNA samples of six transgenic founder mice and one
wild-type mouse were digested with BamHI and examined by South-
ern blot analysis, using a MEK1(E) cDNA probe. Ten micrograms of
DNA was loaded in each lane. An expected 2.8-kb band was detected
in all founder mice. (c) A 550-bp was detected from the tail DNA of
MEK1(E) transgenic mice by PCR, using Ap and K1p primers. One-
kilobase maker from Gibco-BRL was used as a standard marker. (B)
Biochemical characterization of the transgenic mice. (a) Total lens
homogenates from two 3-week-old F2 transgenic mice (1 and 3) and
one wild-type littermate were examined by a 10% Coomassie-stained
gel. Twenty micrograms of protein was loaded in each lane. (b) The
same samples in (a) were examined for MEK1(E) protein by an anti-
MEK1 antibody. The MEK1(E) protein band was detected only in the
lens homogenates of the MEK1(E) transgenic mice and not in that of
the wild-type mouse. (c) The same samples in (a) were examined for
MP26, the lens major membrane protein, by an anti-MP26 specific
antibody. (d) An increase in several phospho-tyrosine proteins (ar-
rows) was detected in the transgenic samples when compared with
that of the wild-type control by an anti–phospho-tyrosine antibody.
The molecular weight markers (kDa) are indicated on the left side of
the figures. (C) The immunohistochemical staining of the MEK1(E) and
c-maf transcription factor in the frozen lens sections of 3-week-old
MEK1(E) transgenic mice by their specific antibodies. (a) A phase
photograph of the section with the lens epithelial cells indicated by an
arrow. (b) The FITC-stained result of the anti-MEK1 antibody. (c) The
RITC-stained result of anti-c-maf antibody. (d) The merged picture of
(b) and (c). Scale bar, 20 mm. The anti-MEK1 antibody is the same
antibody used for the staining of the wild-type lens section in Figure
1B. The transcription factor c-maf was used as the marker for the
cellular nucleus of the differentiating fibers in the bow region (C,c).
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RESULTS
Presence of the Activated ERK Pathway in Lens
Epithelial Cells and in Differentiating Fibers
The transcripts of ERK1, ERK2, MEK1, and MEK2 genes were
detected by RT-PCR analysis (data not shown).
MEK2, ERK1, and ERK2 proteins, as well as the phosphor-
ylated (active) forms of ERK1 and ERK2, were detected in the
homogenates of the total lens and lens cortex by Western
blotting (Fig. 1A, lanes 1 and 2). The ERK2 protein was found
in the lens nuclear homogenate, but no phosphorylated forms
of ERK2, ERK1 and MEK2 were detected (Fig. 1A, lane 3). The
endogenous MEK1 was undetectable in these homogenates
through Western blotting, using an anti-MEK1 antibody that
recognized both MEK1 and active mutant MEK1(E) proteins
(see Fig. 6, the MEK1(E) panel).
Phosphorylated (active) forms of ERK1 and ERK2 were
detected with fluorescence by immunohistochemical staining
in both the cellular nucleus of differentiating fiber cells and in
the lens epithelial cells, using an antibody against the phos-
phorylated forms of pERK (Fig. 1B, top right). The endogenous
MEK1 protein was detected only in lens epithelial cells by the
same anti-MEK1 antibody used in the Western blotting (indi-
cated by an arrow in the bottom right of Fig. 1B). The MEK2
antigen was detected in both the epithelial and fiber cells by
the anti-MEK2 antibody (data not shown).
Generation and Characterization of the MEK1(E)
Transgenic Mice
Six MEK1(E) transgenic founder mice were generated (Fig.
2A). These founder mice were mated with wild-type C57BL/6J
mice to generate F1 transgenic mice. F2 mice were generated
FIGURE 3. Macrophthalmia and cataracts in the MEK1(E) transgenic mice. (A) This is an anterior view of two pairs of lenses from a transgenic
mouse (the right pair) and a wild-type littermate (the left pair) at the age of 3 weeks. Cataracts were located in the cortical region of the MEK1(E)
lenses. (B) Anterior view of two pairs of lenses from a transgenic mouse (the right pair) and a wild-type littermate (the left pair) at the age of 5
weeks. Both cortical and nuclear cataracts were observed in the MEK1(E) lenses. (C) Two pairs of eyes from a transgenic mouse (the right pair)
and a wild-type littermate (the left pair) at the age of 5 weeks. The size of the MEK1(E) eye was significantly larger than that of the wild-type eye.
(D) This is a magnified anterior view of cataracts in a 5-week-old MEK1(E) lens. Scale bar, 1 mm.
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from either an inter-cross between the F1 transgenic mice or
an inter-cross between the F1 transgenic mice and F1 wild-type
mice. The F1 and F2 mice from three independent founder
lines, 7, 20, and 14, were used for various analyses.
Lens Cell Expression of Transgenic MEK1(E)
Protein and Changes in Phospho-Tyrosin
Proteins in MEK1(E) Transgenic Lenses
No obvious changes in the protein profile of the total lens
homogenates between the wild-type and MEK1(E) transgenic
mice were observed in a Coomassie-stained gel (Fig. 2B,a).
However, the MEK1(E) protein was detected through Western
blotting only in samples of MEK1(E) transgenic mice (Fig.
2B,b). There was no detectable change in the level of MP26
(the lens major membrane protein) among the homogenates of
MEK1(E) and wild-type lenses (Fig. 2B,c). There was, however,
an increase in the signal intensity of several phospho-tyrosine
protein bands (indicated by arrows in Fig. 2B,d) in the
MEK1(E) lens homogenate when compared with the wild-type
control, using an anti-phospho-tyrosine antibody for detection.
This result is consistent with the observation of an elevated
activity of ERKs in the MEK1(E) transgenic lenses (Fig. 6A,
pERK and pELK-1 panels).
Moreover, the MEK1(E) protein was detected in the differ-
entiating fibers by immunohistochemical staining, using an
anti-MEK1 antibody (Fig. 2C,b). This is the same anti-MEK1
antibody used for detecting the endogenous MEK1 in the lens
epithelial cells in Figure 1C and for the Western blotting. The
positive signal in the epithelial cells of the MEK1(E) transgenic
mice (indicated by an arrow in the Fig. 2C,b) is relatively lower
than that of the wild-type control (shown in 1B), and this is due
to the fact that a very intense and diffuse fluorescent signal of
the transgene product MEK1(E) was detected in the cytosol of
adjacent fiber cells.
These results indicate that the presence of MEK1(E) causes
both an elevation in ERK kinase activity and an alteration in the
phospho-tyrosine proteins in the mouse lenses.
Postnatal Development of Cataracts and
Macrophthalmia in MEK1(E) Transgenic Mice
In comparison to the lenses of their wild-type littermates, all
the transgenic mice postnatally developed macrophthalmia
FIGURE 4. Histologic analysis of the
MEK1(E) and wild-type lenses. Rep-
resentative hematoxylin-eosin–stained
sections of the lenses of MEK1(E)
transgenic and wild-type mice. Scale
bar, 0.25 mm. Lens sections along
the visual axis from a 1-day-old wild-
type mouse (A) and a 1-day-old trans-
genic mouse (B). Eye sections along
the visual axis from a 5-week-old
wild-type mouse (C) and a 5-week-
old transgenic mouse (D). (E and F)
Magnified view at the lens bow re-
gions of (C) and (D), respectively.
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with cataracts. The offspring of the transgenic mouse lines 7
and 20 were used for the phenotypic analysis.
The increase in the size of the eyeball (Fig. 3C) and the
development of enlarged cataractous lenses (Figs. 3A, 3B) can
be observed by direct visual examination. Vacuole formation in
the lens cortex varied among individual transgenic mice. Dis-
rupted fibers were observed only in the lens cortex of the
MEK1(E) transgenic lenses (Fig. 3D). No dramatic lens mor-
phologic changes were detected in 1-day-old transgenic lenses
when compared with the wild-type lenses (Figs. 4A, 4B), al-
though a few swollen fibers with no vacuoles were observed in
the 1-day-old transgenic lenses (data not shown). However, in
a 5-week-old transgenic lens, a number of cytoplasmic vacu-
oles, or enlarged intercellular spaces, were observed in cortical
regions (Fig. 4D). These vacuoles first appeared in the bow
regions of the equator and then spread to the anterior side (Fig.
4F). Furthermore, both enlarged extracellular space and vacu-
oles were detected in MEK1(E) lens fibers by TEM analysis (Fig.
5). No obvious morphologic changes in the lens epithelial cells
were observed in the transgenic mice (data not shown). In the
3- to 4-week-old transgenic mice, the other tissues of the eye,
including the retina and the cornea, did not show obvious
pathologic features aside from an enlargement, which was true
of the whole eyeball. No swollen fibers or vacuoles appeared in
the lens sections of the wild-type littermates (Figs. 4C, 4E).
Eye Weight, Lens Weight, Lens Total Proteins,
and Water-Soluble Crystallins as a Function of
Age in MEK1(E) Transgenic Mice
The growth curves of both the eye and the lens were deter-
mined by measuring their total wet weight. An increase in the
weight of the eye and the lens of the MEK1(E) transgenic mice
was found after 2 weeks of age, compared with that of the
wild-type mice (Table 1 and Figs. 6A, 6B). The increase in the
volume of the lens and the eye was directly correlated with
their increase in weight (representative data shown in Table 2).
There was a 40% increase in the wet weight of the MEK1(E)
lenses of 4-week-old mice compared with that of the wild-type
controls (Table 2). However, the lens dry weight of the
MEK1(E) lenses was almost the same as that of their wild-type
littermates (Fig. 6C). These data were obtained from the trans-
genic mice of line 7. The phenotypes of the transgenic mice of
line 20, macrophthalmia with enlarged cataractous lenses, pro-
gressed much faster and more severely than those of line 7.
The average increase in the eye weight was 50% when com-
pared with their wild-type littermates at the age of 4 weeks,
whereas the average wet weight increase in their lenses was
65% (results taken from 4 transgenic and 4 wild-type mice).
The phenotypic variation between line 20 and 7 is possibly due
to the fact that the 20 founder mouse had four times more
MEK1(E) transgene copies than the seven founder mouse,
according to the intensity of the hybridized bands (in Fig.
2A,b), as defined by phosphoimager analysis. It is also possible
that, aside from the higher copy number of the transgene,
other factors may have contributed to the severe phenotype in
line 20.
There were no significant changes in the total lens proteins
in the heavier transgenic lenses when compared with the
wild-type lenses at 3 and 4 weeks of age (Fig. 6D).
Water-soluble homogenates were prepared from the lenses
of both transgenic and wild-type mice at the ages of 2 weeks,
4 weeks, and 2.5 months and were then studied by gel filtration
analysis. No obvious changes in the distribution of a-, b-, and
g-crystallins were found in the samples from transgenic lenses
of 2- to 4-week-old mice when compared with that of wild-type
mice at the same age. A representative result is shown (Fig. 6E).
However, a significant loss of g-crystallin was found in the
sample of 2.5-month-old transgenic lenses with nuclear cata-
racts (Fig. 6F).
Selective Upregulation of GLUT1 and an Elevated
Glucose Level in MEK1(E) Transgenic Lenses
We have found that lens-specific expression of the MEK1(E)
led to an approximately twofold increase in the phosphor-
ylated ERK1 and ERK2 kinase (pERK), as well as in their
kinase activities (measured via pELK-1; Fig. 7A). These re-
sults were determined by densitometric measurements from
more than three sets of experiments. No detectable changes
in the other MAP kinases, such as the MEK2 kinase, the
phosphorylated form of p38a kinase, or the phosphorylated
form of c-Jun N-terminal kinase 1 (pJNK1), were found in
the MEK1(E) lens homogenates by Western blotting (Fig.
7A). Similarly, there were no detectable changes in the
levels of several major lens membrane proteins, including
MP26, MP20, connexin a3 and a8, and the chloride channel
FIGURE 5. Electron micrographs demonstrating the presence of both
enlarged extracellular space and vacuoles in MEK1(E) lens fibers. (A)
Lens fibers from 3-week-old wild-type mice. (B) Lens fibers from
3-week-old MEK1(E) mice from line 7. Scale bar, 2 mm.
TABLE 1. Comparison of the Eye Weight and the Lens Weight of Wild-Type and MEK1(E) Mice at Different Ages
Age
1 Week 2 Weeks 3 Weeks 4 Weeks 5 Weeks 6 Weeks
Wildtype lenses (mg) 1.53 6 0.12 (6) 2.68 6 0.12 (6) 3.67 6 0.21 (8) 3.76 6 0.12 (8) 4.60 6 0.22 (4) 4.75 6 0.39 (14)
Wildtype eyes (mg) 9.56 6 0.23 (5) 13.8 6 0.26 (6) 14.2 6 0.35 (8) 15.0 6 0.64 (13) 16.5 6 1.0 (6)
MEK1(E) lenses (mg) 1.43 6 0.19 (11) 3.28 6 0.31 (6) 4.26 6 0.14 (6) 5.13 6 0.42 (8) 6.10 6 0.71 (6) 6.38 6 0.42 (7)
MEK1(E) eyes (mg) 9.01 6 0.59 (10) 15.4 6 0.71 (6) 16.5 6 0.58 (6) 18.3 6 1.3 (13) 20.9 6 2.1 (8)
Values in parentheses are number of mice.
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CIC3 (Fig. 7A). However, we have found that there was at
least a fourfold increase in the glucose transporter 1
(GLUT1) protein level in the decapsulated MEK1(E) lens
homogenates when compared with that in the wild-type
controls. This was determined through a densitometric anal-
ysis from Western blot results of six sets of experiments.
This increase in the GLUT1 level was also detected in lens
samples of 2-week-old MEK1(E) mice (data not shown). No
FIGURE 6. Comparison of the eye weight, the lens weight, lens total proteins, and water-soluble crystallins between MEK1(E) transgenic and
wild-type mice. (A) Eye wet weight as a function of mouse age. (B) Lens wet weight as a function of mouse age. (C) Lens dry weight as a function
of mouse age. (D) Lens total protein amount as a function of the mouse age. (E) Elution profiles of the total water soluble proteins from two lenses
of MEK1(E) transgenic and wild-type mice at the age of 4 weeks. a, b, and g peaks correspond to the three major classes of crystallins. Gel filtration
analysis was performed as described in the text.25 At least three pairs of lens samples from each of the transgenic and wild-type mice of the same
age were analyzed by the gel filtration method. (F) Elution profiles of the total water-soluble proteins from the lenses of the MEK1(E) transgenic
and wild-type mice at the age of 2.5 months. a, b, and g peaks correspond to the three major classes of crystallins.
TABLE 2. Comparison of the Increase of Weight and Volume of the Eyes and Lenses of Wild-Type and MEK1(E) Mice at Age of 4 Weeks
Eye Weight (mg) Eye Volume (mm3) Lens Weight (mg) Lens Volume (mm3)
Wild type 14.8 6 0.7 (5) 15.7 6 1.3 (5) 3.66 6 0.19 (5) 3.78 6 0.31 (5)
MEK1(E) 19.6 6 0.5 (5) 22.7 6 1.1 (5) 5.15 6 0.26 (4) 5.82 6 0.42 (4)
Increase of MEK1(E) (%) 32 44 40 54
Values in parentheses are number of mice.
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detectable change in the glucose transporter 3 (GLUT3)
protein level was observed (Fig. 7A). There was a more than
80% increase in the glucose level in the MEK1(E) lenses
when compared with that in the wild-type mice (Fig. 7B).
DISCUSSION
The lens may be viewed as an asymmetrical syncytial organ
characterized by a functional and vectorial organization. The
maintenance of the electrochemical gradient across the lens
relies on the presence in the epithelial monolayer and in the
outer cortical differentiating fibers of sources for active metab-
olism and energy production for active transport.26 Cell–cell
communication between epithelial and fiber cells throughout
the lenticular mass depends on the presence of junctional
domains of low electrical resistance and membrane sites of
increased permeability for small ions and water.27–30
It is noteworthy that active forms of ERK1 and ERK2 were
found in both the lens epithelial cells and in the differentiating
fiber cells, suggesting that mitogen-activated protein kinases
operate in a lens domain where the maintenance of the elec-
trochemical gradient across the lens is actively regulated. In
this study, we have selected a constitutively active mutant of
MEK1(E) instead of an active mutant of MEK2 to activate the
ERK pathway in the lens. This is for three reasons: (1) MEK1
and MEK2 are equivalent in terms of the activation of ERKs; (2)
we can distinguish the transgene MEK1(E) from the endoge-
nous MEK2 in the lens fibers by Western blotting; and (3) the
endogenous MEK1 in the lens fibers is undetectable by West-
ern blotting. It is striking that, in transgenic mice expressing
MEK1(E) that was driven to the lens by the aA-crystallin pro-
moter, cataracts and macrophthalmia developed. It is therefore
likely that the lens-specific expression of MEK1(E) and/or an
elevated ERK pathway activity selectively alters properties of
downstream targets, including glucose metabolism and, in
turn, the cataract formation of the lens. Given the fact that the
ERK pathway plays an essential role in controlling cell prolif-
eration and differentiation, it is surprising that a disruption of
secondary fiber cells is the predominant defect in the MEK1(E)
transgenic lenses. The fact that there were no obvious changes
in the lens epithelial cells might be due to the absence of the
MEK1(E) transgene product, because the aA-crystallin pro-
moter has been reported to be inactive in the epithelial cells.15
Currently, we do not know why we did not observe any
obvious defects in the primary fibers, where transgenes should
be expressed. Because we were unable to distinguish MEK1(E)
from endogenous MEK1 in these cells with anti-MEK1 antibod-
ies, further studies will be required for any interpretations
about the primary fibers of MEK1(E) lenses.
The question remains, however, whether the actual mech-
anism generating intra-cytoplasmic vacuoles and enlarged in-
tercellular spaces is restricted to the cortical lens region. We
assumed that water is retained in the lens cortical region in
parallel with an increase in the pressure via an elevated level of
ions and other osmolytes. The presence of extensive swelling
of cytoplasmic membrane compartments and intercellular
spaces would reflect dramatic changes in the function of spe-
cific membrane transporters in the cortical fibers of the trans-
genic lenses. It is likely that this transporter is one of the
downstream targets of the ERK pathway, which regulates the
balance in the cortical fibers of the lens. Several published
articles have shown that similar cataracts were observed in
lenses after they were treated with chloride channel blocker
5-nitro-2-(3-phenylpropylamin) benzoate (NPPB) and tamox-
ifen.31,32 Although there were no changes in the protein level
of chloride channel CIC3 or in the water channel protein
MP2633 in the MEK1(E) lens fibers, we still do not know
whether their functions are normal. It has been reported that
the MEK1 kinase may have an ERK-independent downstream
pathway,34 although we have no evidence as of yet to show
this novel pathway in the lens.
FIGURE 7. Elevated levels of GLUT1 and glucose in the lenses of the
MEK1(E) transgenic mice. (A) Homogenates prepared from the decap-
sulated lenses of the 3-week-old F2 transgenic and wild-type mice were
used for both the kinase activity assay and Western blot analysis.
Representative results are from more than three different sets of ex-
periments. The pELK-1 panel was determined by the kinase assay of
the ERK activity by using a recombinant ELK-1 protein as the substrate
of ERK1 and ERK2 kinases; all other panels are lens endogenous
proteins detected by their specific antibodies. There was an approxi-
mately twofold increase in the phosphorylated forms of ERKs (pERK)
as well as in their activities (pELK-1) in the MEK1(E) lens sample when
compared with that of the wild-type control. There were no detectable
changes in MEK2, p38a (a phosphorylated form), pJNK1 (a phosphor-
ylated form), a3 connexin, a8 connexin, MP26, MP20, or the chloride
channel CIC-3 in the MEK1(E) lens. However, there was a significant
increase in the GLUT1 protein level (at least fourfold, as determined by
a densitometric analysis) in the decapsulated MEK1(E) lens homoge-
nate when compared with the wild-type control. There were no
detectable changes in the GLUT3 level in these MEK1(E) samples. The
molecular weight markers (kDa) are indicated on the right side of the
figures. (B) Lens glucose level as a function of age in the wild-type mice
(n 5 6) and transgenic mice (n 5 16). The lens glucose level was
measured from the deproteinized total lens homogenates of the mice
at 3 and 4 weeks of age.
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Glucose Transporter and Cataractogenesis
Diabetic cataract formation is associated with swelling fibers
and vacuole formation in the lens cortex, which subsequently
cause nuclear cataracts.6 Cataract formation in the MEK1(E)
transgenic mice, to a certain degree, resembled some of the
lens pathologic processes in diabetic cataractogenesis.
Our hypothesis is that the selective upregulation of GLUT1
partly contributes to the lens phenotype of the MEK1(E) trans-
genic mice. An elevated GLUT1 level could cause an increase in
the influx of glucose into the lens (the glucose level is ;1
mM)35 from the aqueous or vitreous humor (;15–30 mM).36
Subsequently, an altered glucose metabolism in the lens cells
can lead to an increase in the sorbitol level via the reaction
catalyzed by aldose reductase,37,38 nonenzymatic modification
of lens proteins,6 and oxidative stress.7 All these changes even-
tually induce cataract formation.
It was recently reported that GLUT1 is expressed and lo-
cated in the epithelial cells and in the newly differentiating
fiber cells.39 It has also been reported that the rate-limiting
factor for the influx of glucose into the cells is dependent on
the level of the glucose transporter in the plasma membrane in
vivo and in vitro.40 An overexpression of GLUT1 in the muscle
cells of transgenic mice caused an increase in the influx of
glucose into these cells.41 Certain specific cis-elements in the
GLUT1 gene promoter were responsible for the stimulation of
the ERK pathway.42 Activation of the ERK pathway can stim-
ulate expression of the GLUT1 gene in cardiac myocytes43 and
adipose tissue.44 Therefore, it is likely that glucose transport
and metabolism are regulated by the ERK pathway in the lens.
We may then hypothesize that the ERK pathway is involved
in cataract formation. The high glucose levels not only cause an
increase in the influx of glucose into the lens cells but also
activate the ERK pathway. An elevated intracellular glucose
level via activated ERK pathways is one of the factors for
subsequent cataract formation. Certainly, the other down-
stream targets of the ERK pathways may also contribute to
cataract formation in MEK1(E) transgenic mice. We are in the
process of identifying these other downstream targets of the
ERK pathway in the lens.
Regulation of Eye Size
The phenotype of the MEK1(E) transgenic mice, macrophthal-
mia with cataractous lenses, is unique. Dozens of different
transgenic mice have been reported to develop various eye
and/or lens phenotypes by using the same aA-crystallin pro-
moter to express many different genes, including FGF, FGF
receptor,45 and myo-inositol transporter.46 However, although
some did develop microphthalmia, neither these transgenic
mice nor gene knockout mice47,48 have been reported to
develop macrophthalmia.
The factors that control the growth of the eyeball are largely
unknown.49 There are human genetic diseases linked to mac-
rophthalmia.50 A recently published article suggests that an
enlarged eye could be the result of an increase in the embry-
onic eye field.51 However, the phenotype of the MEK1(E)
transgenic mice suggest that the size of the eye may be post-
natally regulated by the size of the lens. Therefore, there are at
least two distinct mechanisms that control the growth of the
eyeball.
In summary, we believe that the MEK1(E) transgenic mice
may be useful for studying not only the molecular mechanism
that controls cataract formation but also the mechanisms that
control the size of the entire eye.
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E R R A T A
Erratum in: “Macular Pigment in Donor Eyes with and without AMD: A Case-Control Study”
by Bone et al. (Invest Ophthalmol Vis Sci. 2001;42:235–240).
In the Discussion on p. 238, the two citations to Figure 5 were incorrectly stated. The first
reference should have read: Figure 5 (filled circles) shows the odds ratios plotted against the
median values for these quartiles.
The second citation should read: Odds ratios, shown in Figure 5 (open circles), could then
be calculated from an analysis of these numbers and the “control” numbers in the first column.
Erratum in: “Identification of Ocular Cicatricial Pemphigoid Antibody Binding Site(s) in
Human b4 Integrin” by Kumari et al. (Invest Ophthalmol Vis Sci. 2001;42:379–385).
On p. 379 and in the Table of Contents, two authors’ names were inadvertently misspelled.
The names should have read: Mohammed S. Razzaque and A. Razzaque Ahmed.
Accordingly, the corresponding author’s email address should also read: razzaque_ahmed@
hms.harvard.edu.
The online version of this article was corrected on January 31, 2001.
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